However, when ZFP36L2 iTregs were co-injected, no significant improvement was observed on histological evaluation of the colitis nor the body weight, suggesting that ZFP36L2 iTregs have limited suppression function in vivo. The gene discussed is ZFP36L2; the disease is colitis.